To evaluate the prognostic potential of FBLN2 expression in breast cancer patients, we assessed the relevance of Fbln2 mRNA expression to patients’ survival status using data from the KM plotter and METABRIC. The gene discussed is FBLN2; the disease is breast carcinoma.